Muscle Metabolic Function in Older Adults With Different Vitamin D Status Before and After Exercise
NCT ID: NCT02485197
Last Updated: 2017-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2013-03-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D and Muscle Metabolic Function
NCT02221596
Supplementary Intake of Vitamin D During 12 Weeks Strength Training in Younger and Older People
NCT01252381
Vitamin D Status and Muscle Function
NCT02858882
Impact of Vitamin D on 25-hydroxyvitamin D Levels and Physical Function
NCT02293187
Vitamin D and Physical Function in Older Adults
NCT00710957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low 25(OH)D
We will recruit individuals with low 25(OH)D (\<30ng/mL).
7 continuous days of aerobic training
For 7 consecutive days, subjects will perform up to 45 minutes of exercise consisting of treadmill walking at a progressive intensity of about 60-65% of their maximum heart rate. This heart rate range is estimated to be below 60% VO2 max.
High 25(OH)D
We will recruit individuals with higher 25(OH)D (at least 20ng/mL units higher then that of the "low 25(OH)D group).
7 continuous days of aerobic training
For 7 consecutive days, subjects will perform up to 45 minutes of exercise consisting of treadmill walking at a progressive intensity of about 60-65% of their maximum heart rate. This heart rate range is estimated to be below 60% VO2 max.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
7 continuous days of aerobic training
For 7 consecutive days, subjects will perform up to 45 minutes of exercise consisting of treadmill walking at a progressive intensity of about 60-65% of their maximum heart rate. This heart rate range is estimated to be below 60% VO2 max.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled diabetes or hypertension.
* History of neurological conditions related to spinal derangement, disk disease, peripheral neuropathies, tremor and rigidity
* History of leg/hip trauma, inflammation, infection rhabdomyolysis, or leg surgery in the past 3 months
* Have a diagnosis of osteoporosis (as determined by DXA)
* Participated in a resistance or aerobic training program in the last 3 months
* Engage in more than 1 hr/week of vigorous activity
* Body mass index \>29
* On hormone replacement therapy
65 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
David Travis Thomas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Travis Thomas
Ph.D., RD, CSSD, CSCS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David T Thomas, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky
Maja Redzic, MS
Role: STUDY_DIRECTOR
University of Kentucky
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kentucky
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-1029-F6A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.